A
NVAX icon

AlphaQuest’s Novavax NVAX Stock Holding History

AlphaQuest’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,422
Closed -$204K – 1380
2025
Q4 		$204K Buy
30,422
+4,510
+17% +$34K 0.01% 1439
2025
Q3 		$225K Buy
25,912
+20,976
+425% +$163K 0.01% 1342
2025
Q2 		$31.1K Sell
4,936
-34,698
-88% -$230K ﹤0.01% 1727
2025
Q1 		$254K Buy
39,634
+28,957
+271% +$239K 0.03% 871
2024
Q4 		$85.8K Buy
10,677
+7,940
+290% +$76.5K 0.01% 1137
2024
Q3 		$34.6K Sell
2,737
-44,090
-94% -$569K ﹤0.01% 1465
2024
Q2 		$593K Buy
+46,827
New +$471K 0.08% 401

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AlphaQuest's NVAX Position: Q1 2026 in Review

AlphaQuest sold out of Novavax (NVAX) in Q1 2026, closing a stake of 30,422 shares — an estimated $204K sold.

AlphaQuest first reported a position in NVAX in Q2 2024 and held it in 7 quarters. The position peaked at $593K in Q2 2024. 259 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • AlphaQuest reported no remaining Novavax position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 30,422 Novavax shares in Q1 2026, an estimated $204K.
  • AlphaQuest first reported a position in Novavax in Q2 2024 and held it in 7 quarters.
  • AlphaQuest's Novavax position peaked at $593K in Q2 2024.
  • 259 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.